← All stocks

Ascendis Pharma A/S

ASND Net selling

CIK 0001612042 #733 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$872.90K

$0.00 on a plan · $810.57K straight out of an exercise

Sold at will

$62.33K

1 of 2 sales

Net

−$872.90K

−$62.33K against sales at will

By person

5 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bodenhoff Mads

SVP & PAO

—

$810.57K (1) scheduled

−$810.57K

0.0000%

$0.00

—

HOLTUG LARS

Director

—

$62.33K (1)

−$62.33K

4,000

0.0065%

$1.08M

−5.6%

SMITH SCOTT THOMAS

EVP & Chief Financial Officer

—

4,367

0.0070%

$1.18M

+8.7%

BIENAIME JEAN JACQUES

Director

—

2,900

0.0047%

$783.55K

—

JENSEN FLEMMING STEEN

See Remarks

—

0.0000%

$0.00

−100.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Bodenhoff Mads

8 Sep 2026

SVP & PAO

Sold after exercise

3,000

$270.19

$810.57K

Show all 2 transactions →

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 3,000

History held since 12 May 2026